Document Type : Original Article
Authors
1 Research Center for Cancer Epidemiology and Screening, Aja University of Medical Sciences, Tehran, Iran and Infectious Diseases Research Center, Aja University of Medical Sciences, Tehran, Iran
2 Department of molecular and cellular biology, Faculty of Basic Science, Ale-Taha Institute of Higher Education, Tehran, Iran
Abstract
Renal Cell Carcinomas (RCC) are a wide range of heterogeneous tumors that mainly originate in renal tubular epithelial cells. These carcinomas are more common in males older than 60. Studies have shown that overexpression of the Long Non-Coding RNA (lncRNA) TCL6, which is a lncRNA with roles in T-cell lymphoproliferative diseases, could suppress the proliferation and growth of Clear Cell RCC (ccRCC) cells. The present study intended to investigate the association of this specific lncRNA with ccRCC by comparing the expression levels in cancerous tissues with the adjacent normal tissues.
The study included 44 samples of ccRCC cells and healthy, adjacent tissue from the affected patients. The expression levels of TCL6 lncRNA were assessed in the cancerous tissues and the adjacent normal tissues using real-time PCR.
According to the results, TCL6 lncRNA was significantly underexpressed in the cancerous tissues than the adjacent normal tissues.
In conclusion, these findings indicated that TCL6 might have roles in the tumorigenesis regulation and development of RCC.
Keywords
387, no. 10021, pp. 894–906, 2016.
2. R.L. Siegel, K.D. Miller, and A. Jemal,“Cancerstatistics, 2017,”
CA: A Cancer Journal for Clinicians,vol.67,no.1,pp.7–30,2017.
3. H. Moch,A. L. Cubilla, P. A. Humphrey,V. E.Reuter, andT. M.
Ulbright, “The 2016 WHO classification of tumours of the urinary
system and male genital organs—part A: renal, penile,and testicular
tumours,” European Urology,vol.70,no.1,pp.93–105, 2016.
4. F. E. Vera-Badillo, A. J. Templeton, I. Duran et al., “Systemic
therapy for non-clear cell renal cell carcinomas: A systematic
review and meta-analysis,” European Urology,vol.67,no.4,pp.
740–749, 2015.
5. Y. Sato, T. Yoshizato, Y. Shiraishi et al., “Integrated molecular
analysis of clear-cell renal cell carcinoma,” Nature Genetics,vol.
45,no.8,pp.860–867,2013.
6. H. Butz, P. M. Szab´o, R. Nofech-Mozes et al., “Integrative
bioinformatics analysis reveals new prognostic biomarkers of clear
cell renal cell carcinoma,” Clinical Chemistry, vol.60,no. 10, pp.
1314–1326, 2014.
7. L. Cari, G. Nocentini, G. Migliorati, and C. Riccardi,
“Potential effect of tumor-specific Treg-targeted antibodies in
the treatment of human cancers: A bioinformatics analysis,”
OncoImmunology,vol.7,no.2,2018.
8. M. Huarte,“Theemergingroleoflnc RNA sincancer, ”Nature
Medicine, vol. 21, no. 11, pp. 1253–1261, 2015.
9. A. Fatica and I. Bozzoni, “Long non-coding RNAs: new
players in cell differentiation and development,” Nature Reviews
Genetics,vol.15,no.1,pp.7–21,2014.
10. C. Lin and L. Yang, “Long Non-coding RNA in Cancer: Wiring
Signaling Circuitry,” Trends in Cell Biology,vol. 28,no. 4, pp. 287–
301, 2018.
11. L. Salmena, L. Poliseno, Y. Tay, L. Kats, and P. P. Pandolfi, “A
ceRNA hypothesis: the rosetta stone of a hidden RNA language?”
Cell,vol.146,no.3,pp.353–358,2011.
12. M.Lv,Z. Zhong, M.Huang, Q.Tian, R. Jiang, andJ.Chen,
“lncRNA H19 regulates epithelial–mesenchymal transition
and metastasis of bladder cancer by miR-29b-3p as competing
endogenous RNA,” Biochimica et Biophysica Acta (BBA)
Molecular Cell Research, vol. 1864, no. 10, pp. 1887–1899, 2017.
13. G. Liu, Z. Ye, X. Zhao, and Z. Ji, “SP1-induced up-regulation
of lncRNA SNHG14 as a ceRNA promotes migration and invasion
of clear cell renal cell carcinoma by regulating NWASP,” American
Journal of Cancer Research,vol.7,no.12,pp.2515–2525, 2017.
)